Skip to content

Bidirectional cohort study of the effect of perioperative risk factors on prognostic patients with gastric cancer

Bidirectional cohort study of the effect of perioperative risk factors on prognostic patients with gastric cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051131
Enrollment
Unknown
Registered
2021-09-14
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Case series:Radical gastrectomy for gastric cancer

Sponsors

Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily joined the study and signed the informed consent; 2. Aged 18-75 years, no gender limit; 3. Pathologically diagnosed gastric cancer patients; 4. Plan to undergo radical gastrectomy for gastric cancer.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients; 2. Patients of childbearing age have a positive pregnancy test at baseline; 3. Other malignant tumors in the past 5 years (except basal cell or squamous cell carcinoma, superficial bladder cancer, in situ cervical cancer or breast cancer); 4. Severe cardiovascular disease within 12 months before enrollment, such as symptomatic coronary heart disease, congestive heart failure >= grade II, uncontrolled arrhythmia, myocardial infarction; 5. Complicated severe uncontrolled concurrent infection or other severe uncontrolled concomitant disease, moderate or severe renal impairment.

Design outcomes

Primary

MeasureTime frame
complication;

Countries

China

Contacts

Public ContactXia Xiang

Renji Hospital, Shanghai Jiaotong University School of Medicine

xiangmoumou@163.com+86 13651810863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026